Jennifer Buell
Tracked across 1 events · 12 articles · First seen Apr 03, 2026 · Last active May 28, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Impact: Jennifer Buell, President and CEO of MiNK Therapeutics, provided commentary on the positive trial results and the potential of agenT-797.
Apr 03, 2026 · 12 articles
ERGEN INTELLIGENCE
Track Jennifer Buell live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard